Nova Biomedical is a global leader in in vitro diagnostics, recognized for its cutting-edge solutions in critical care testing, point-of-care diagnostics, and biotechnology analysis. With over 40 years of expertise, Nova develops innovative blood gas, electrolyte, and cell culture analyzers that enhance patient care and streamline medical processes.

Operating in more than 100 countries through subsidiaries and distributors, Nova ensures reliable support and exceptional customer service worldwide. Its commitment to technological innovation and collaboration with the medical community drives advancements in diagnostic accuracy and efficiency, making Nova a trusted partner in healthcare.